Skip to main content
Clinical Trials/ISRCTN12233792
ISRCTN12233792
Completed
N/A

EffectiveNess of feEding protocol on nutritional thErapy and clinical outcomes in critically ill patients: a multi-centered, cluster-ranDomized, parallel-controlled trial

anjing Central Hospital0 sites2,772 target enrollmentNovember 24, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Critically ill patients
Sponsor
anjing Central Hospital
Enrollment
2772
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36118758/ (added 20/09/2022) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/36314372 Secondary analysis (added 20/12/2023) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35767914/ Secondary analysis (added 20/12/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35172856 (added 20/12/2023) 2024 Results article in https://doi.org/10.1186/s13054-024-04813-6 post hoc analysis (added 22/01/2024)

Registry
who.int
Start Date
November 24, 2017
End Date
December 28, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
anjing Central Hospital

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 15/01/2020:
  • 1\. Informed consent form obtained from the patient or next of kin
  • 2\. Aged 18 years or older
  • 3\. Within 24 h of ICU admission
  • 4\. With one or more organ failure (SOFA for any single organ system\=2\)
  • 5\. Expected to stay in ICU more than 7 days
  • 6\. Oral diet is not likely to be restored within three days
  • Previous inclusion criteria:
  • 1\. All patients expected to stay in ICU for over three days
  • 2\. Aged 18 years and older

Exclusion Criteria

  • Current exclusion criteria as of 15/01/2020:
  • 1\. Received EN in the past 3 days
  • 2\. Receiving palliative treatment or expected to die within 48 hours
  • 3\. Women in pregnancy
  • 4\. Long\-term use of steroids or immunosuppressive agents
  • 5\. Patients with malignant diseases receiving radiotherapy or chemotherapy.
  • Previous exclusion criteria:
  • 1\. Subjects receiving EN in previous 7 days
  • 2\. Contraindications for nasogastric or nasoenteric tube placement
  • 3\. Subjects who have already undergone percutaneous endoscopic jejunostomy (PEJ), percutaneous endoscopic gastrostomy (PEG) and surgical jejunostomy

Outcomes

Primary Outcomes

Not specified

Similar Trials